Impact of US Healthcare Reform on the In Vitro Diagnostics Market

Impact of US Healthcare Reform on the In Vitro Diagnostics Market

Patient Influx and Increased Testing Will Steer Clinical Labs toward ACO Models

RELEASE DATE
26-Jun-2014
REGION
North America
Research Code: NE24-01-00-00-00
SKU: LS00046-NA-MR_16887
$2,450.00
In stock
SKU
LS00046-NA-MR_16887
$2,450.00
Links

Pay by invoice

ENQUIRE NOW

Description

This Market Insight highlights the effects of the US Patient Protection and Affordable Care Act on the in vitro diagnostics (IVD) market, diagnostic test service providers, and IVD manufacturers. The deliverable also focuses on global trends and the outlook for the IVD market. Estimates and trends for all IVD segments—immunochemistry, point-of-care testing, molecular diagnostics, clinical microbiology, tissue diagnostics, hematology, hemostasis, and self-monitoring blood glucose—are provided. Key market drivers and restraints and the competitive landscape for the global market are discussed. The base year is 2013.

Table of Contents

Executive Summary

The Patient Protection and Affordable Care Act

Effects on Clinical Labs

Opportunities for IVD Manufacturers and Clinical Labs

Care Delivery Transformation: Acute Care to Prevention

Opportunity Impact Dashboard

Laboratory Test Reimbursement

Factors Affecting Pathology Labs

Most Impacted Specialty

M&As Declined in 2012 and Remained Flat in 2013

6 Factors Affecting the CLFS

Short-term Projection of CLFS Cuts from the ACA

Projected CLFS Reductions

Affordable Care Act Effects

Accountable Care Organizations

Positioning a Clinical Lab within an ACO Ecosystem

Value of Clinical Analytics to a Clinical Lab

Potential Laboratory Strategies

Demands and Expectations of ACOs

Market Segmentation

Market Overview

Key Market Principles

Test Volume by Specialty

Competitive Landscape

Segment Life Cycle Analysis

Decentralization vs. Centralization

Tissue Diagnostics Segment Snapshot

Tissue Diagnostics Segment—US Pricing Analysis

Tissue Diagnostics Segment—Global Strategies

Tissue Diagnostics Segment—Three Big Predictions

Molecular Diagnostics Segment Snapshot

Molecular Diagnostics Segment—Application Areas

Molecular Diagnostics Segment—Market Size and Growth

Molecular Diagnostics Segment—Next-generation Sequencing Snapshot

Molecular Diagnostics Segment—Evolution of NGS Technologies

Molecular Diagnostics Segment—Applications Based on NGS

Molecular Diagnostics Segment—Key NGS Technology Partnerships and Acquisitions

Molecular Diagnostics Segment—Molecular Technologies in Companion Diagnostics

Molecular Diagnostics Segment—Miniaturization

Molecular Diagnostics Segment—Three Big Predictions

Point-of-care Testing Segment Snapshot

Point-of-care Testing Segment—Sales Breakdown

Point-of-care Testing Segment—POCT vs. Laboratory Testing

Point-of-care Testing Segment—Key Trends

Point-of-care Testing Segment—Key Trends (continued)

Point-of-care Testing Segment—Metrics Analysis

Point-of-care Testing Segment—Metrics Analysis (continued)

Point-of-care Testing Segment—Potential Opportunities

Point-of-care Testing Segment—Three Big Predictions

Self-monitoring Blood Glucose Segment Snapshot

Self-monitoring Blood Glucose Segment—Test Strips Market Metrics Analysis

Self-monitoring Blood Glucose Segment—Meters Market Metrics Analysis

Self-monitoring Blood Glucose Segment—Product Analysis

Clinical Microbiology Segment Snapshot

Clinical Microbiology Segment—Microbiology Segmentation

Clinical Microbiology Segment—Emerging Opportunities

Clinical Microbiology Segment—Unmet Demands by Manufacturers

Clinical Microbiology Segment—Technology Trends

Hematology Segment Snapshot

Hemostasis Segment Snapshot

Hematology and Hemostasis Segments—Opportunities for Market Vendors

Immunochemistry Segment Snapshot

Immunochemistry Segment—Installed Base

Conclusions

Legal Disclaimer

The Frost & Sullivan Story

Value Proposition

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

Related Research

2016-17 Outlook for Indian Agriculture and Rural Demand

Release Date: 18-May-16
Region: Global

Monthly CPI & WPI Inflation, April 2016

Release Date: 18-May-16
Region: Global

India Investment Tracker January–March 2016

Release Date: 18-May-16
Region: South Asia, Middle East & North Africa

Country Profile – Russia

Release Date: 13-May-16
Region: Asia Pacific

North American Protein Ingredients Market, Forecast to 2020

Release Date: 13-May-16
Region: North America

Global Economic Tracker—Insights and Trends (GET-IT)—Emerging Middle East and Africa Q2 2016

Release Date: 12-May-16
Region: South Asia, Middle East & North Africa

Middle East and North Africa Investment Tracker January-March 2016

Release Date: 11-May-16
Region: South Asia, Middle East & North Africa

Asia-Pacific Telehealth Market Outlook, Forecast to 2020

Release Date: 11-May-16
Region: Asia Pacific

Digital Transformation in the Global Food & Agriculture Market

Release Date: 9-May-2016
Region: North America
This Market Insight highlights the effects of the US Patient Protection and Affordable Care Act on the in vitro diagnostics (IVD) market, diagnostic test service providers, and IVD manufacturers. The deliverable also focuses on global trends and the outlook for the IVD market. Estimates and trends for all IVD segmentsimmunochemistry, point-of-care testing, molecular diagnostics, clinical microbiology, tissue diagnostics, hematology, hemostasis, and self-monitoring blood glucoseare provided. Key market drivers and restraints and the competitive landscape for the global market are discussed. The base year is 2013.
More Information
No Index No
Podcast No
Author Divyaa Ravishankar
WIP Number NE24-01-00-00-00
Is Prebook No